Showing results (81-90 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|February 2, 2013
IDO⁺ DCs and signalling pathwaysYue Wang, Bao-Hong Yang, Hui Li, et al.Current Cancer Drug Targets|April 20, 2013
Natural products and transforming growth factor-beta (TGF-β) signaling in cancer development and progressionChung Lee, Qiang Zhang, James Kozlowski, et al.Current Cancer Drug Targets|April 24, 2013
Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQDeng Chen, Wei Wang, Jiang-Jiang Qin, et al.Current Cancer Drug Targets|April 27, 2013
Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategyGagan Deep, Rajesh AgarwalCurrent Cancer Drug Targets|July 24, 2013
Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of actionSofia A Santos, Alexandra PauloCurrent Cancer Drug Targets|March 23, 2013
Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targetsSophia Adamia, Patrick M Pilarski, Andrew R Belch, et al.Current Cancer Drug Targets|March 23, 2013
Castration-resistant prostate cancer: novel therapeutics pre- or post- taxane administrationMasaki Shiota, Akira Yokomizo, Naohiro Fujimoto, et al.Current Cancer Drug Targets|December 27, 2005
Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignanciesDomenico Ribatti, Angelo VaccaCurrent Cancer Drug Targets|December 27, 2005
Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyJózef Dulak, Alicja JózkowiczCurrent Cancer Drug Targets|December 27, 2005
Therapeutic cancer vaccines: at midway between immunology and pharmacologyA Lage, R Perez, L E FernandezPageof 187